Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label,...
We conducted a randomized, open-label, parallel-controlled, multicenter trial on the use of Shuanghuanglian (SHL), a traditional Chinese patent medicine, in treating cases of COVID-19. A total of 176...